AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Is Biotech Going to Focus on Blood Disorders?
Angelica, I do wonder though, a lot of money gets used recklessly when there is. But at the same time, it also provides open opportunities for developments that really can change the way we're treated. We saw this boom of platform companies as they like to call themselves. So companies that we're working on, many different diseases or all kinds of areas instead of just one drug for one disease. That was sort of the hot theme of 2021. This year already, we're seeing the theme is prioritized.